Enhancement by GOSPEL protein of GAPDH aggregation induced by nitric oxide donor and its inhibition by NAD(.)

María C González1, Jorge M Romero1, María C Ingaramo1

  • 1Departamento de Química Biológica, Facultad de Ciencias Químicas, Centro de Investigaciones en Química Biológica de Córdoba (CIQUIBIC), Universidad Nacional de Córdoba-Consejo Nacional de Investigaciones Científicas y Técnicas (UNC-CONICET), Universidad Nacional de Córdoba, Argentina.

FEBS Letters
|June 11, 2016
PubMed

Insights

GOSPEL protein enhances NO-induced GAPDH aggregation, forming amyloid-like co-aggregates. NAD+ inhibits this aggregation, revealing a new role for GOSPEL and NAD+ in oxidative stress response.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cellular Stress Response

Background:

  • Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) plays a role in apoptosis under oxidative stress.
  • Siah Protein Enhances Life (GOSPEL) protein competes with Siah1 for GAPDH binding, inhibiting nuclear translocation and apoptosis.
  • GAPDH can form amyloid-like aggregates implicated in cell death during stress.

Discussion:

  • This study investigates the in vitro effect of GOSPEL on NO-induced GAPDH aggregation.
  • GOSPEL promotes the formation of GOSPEL-GAPDH co-aggregates with amyloid-like properties.
  • This highlights a novel, potentially detrimental function of GOSPEL distinct from its anti-apoptotic role.

Key Insights:

  • GOSPEL enhances NO-induced aggregation of GAPDH.
  • Formation of GOSPEL-GAPDH co-aggregates with amyloid-like characteristics observed.
  • NAD+ effectively inhibits both GAPDH aggregation and GOSPEL-GAPDH co-aggregation.

Outlook:

  • Further research is needed to elucidate the precise mechanisms of GOSPEL-mediated aggregation.
  • Investigating the physiological relevance of these co-aggregates in cellular processes.
  • Exploring therapeutic strategies targeting GAPDH aggregation and NAD+ levels in oxidative stress conditions.